BioRestorative Therapies Inc (BRTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.23
• Market Cap: $5.25M
• EPS: $-1.46
• 52-Week High: $2.10
• 52-Week Low: $0.19

Market Sentiment

BioRestorative Therapies Inc currently has a Neutral sentiment score of 0.06.

About BioRestorative Therapies Inc

BioRestorative Therapies Inc. (BRTX) is a pioneering life sciences company headquartered in Melville, New York, focused on advancing regenerative medicine through innovative therapies utilizing adult stem cell technology. The company is dedicated to addressing critical unmet medical needs by developing safe and effective treatments grounded in cellular and tissue-based methodologies. With a strategic emphasis on orthopedics, neurology, and other therapeutic areas, BioRestorative Therapies is ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for BioRestorative Therapies Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BRTX pay dividends?

BioRestorative Therapies Inc (BRTX) does not currently pay a regular dividend.

What is BRTX's market cap?

BioRestorative Therapies Inc (BRTX) has a market capitalization of $5.25M with a current stock price of $0.23.